Atopic dermatitis (eczema) guidelines: 2023 American Academy of Allergy, Asthma and Immunology/American College of Allergy, Asthma and Immunology Joint Task Force on Practice Parameters GRADE- and Institute of Medicine-based recommendations

CONCLUSION: These evidence-based recommendations address optimal use of (1) topical treatments (barrier moisturization devices, corticosteroids, calcineurin inhibitors, PDE4 inhibitors [crisaborole], topical JAK inhibitors, occlusive [wet wrap] therapy, adjunctive antimicrobials, application frequency, maintenance therapy), (2) dilute bleach baths, (3) dietary avoidance/elimination, (4) allergen immunotherapy, and (5) systemic treatments (biologics/monoclonal antibodies, small molecule immunosuppressants [cyclosporine, methotrexate, azathioprine, mycophenolate, JAK inhibitors], and systemic corticosteroids) and UV phototherapy (light therapy).PMID:38108679 | DOI:10.1016/j.anai.2023.11.009

Source: Annals of Allergy, Asthma and Immunology - December 18, 2023 Category: Allergy & Immunology Authors: AAAAI/ACAAI JTF Atopic Dermatitis Guideline Panel Derek K Chu Lynda Schneider Rachel Netahe Asiniwasis Mark Boguniewicz Anna De Benedetto Kathy Ellison Winfred T Frazier Matthew Greenhawt Joey Huynh Elaine Kim Jennifer LeBovidge Mary Laura Lind Peter Lio Source Type: research